Multikine® (Leukocyte Interleukin, Injection), or Multikine* -- an investigational immunotherapy under development for the potential treatment of advanced primary head and neck cancer, certain head and neck cancers.
* Multikine is the trademark that CEL-SCI has registered for this investigational therapy, and this proprietary name is subject to FDA review in connection with our future anticipated regulatory submission for approval. Multikine has not been licensed or approved for sale, barter or exchange by the FDA or by any other regulatory agency. Similarly, its safety or efficacy has not been established for any use.
